Belgium's Galapagos is raising about $43 million in a new offering designed to help fund new acquisitions. Galapagos bought Argenta earlier this year for €16.5 million. "Management also remains ambitious to make Galapagos a European biotech leader, and acquisitions may help us to achieve that goal," said CEO Onno van de Stolpe. Story